Senestech, Inc. (SNES) Upgraded to “Hold” at Zacks Investment Research
Senestech, Inc. (NASDAQ:SNES) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued on Thursday.
According to Zacks, “SenesTech, Inc. developed technology for managing animal pest populations through fertility control as opposed to a lethal approach. The Company’s fertility control product candidate, ContraPest(R), will be marketed for use initially in controlling rat infestations. SenesTech, Inc. is based in Flagstaff, Arizona. “
Shares of Senestech (NASDAQ SNES) opened at 1.68 on Thursday. Senestech has a one year low of $1.54 and a one year high of $10.69. The stock’s market cap is $17.35 million. The company has a 50-day moving average price of $1.86 and a 200 day moving average price of $1.86.
Senestech (NASDAQ:SNES) last posted its quarterly earnings data on Thursday, August 10th. The company reported ($0.35) EPS for the quarter, missing the consensus estimate of ($0.28) by ($0.07). The firm had revenue of $0.01 million during the quarter, compared to analysts’ expectations of $0.10 million. Equities research analysts expect that Senestech will post ($1.30) earnings per share for the current year.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by American Banking News and is the property of of American Banking News. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark law. The original version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/12/senestech-inc-snes-upgraded-to-hold-at-zacks-investment-research.html.
In related news, COO Andrew Altman bought 20,000 shares of the company’s stock in a transaction dated Friday, August 18th. The stock was purchased at an average price of $2.77 per share, for a total transaction of $55,400.00. Following the acquisition, the chief operating officer now owns 2,600 shares in the company, valued at $7,202. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Grover T. Wickersham bought 15,000 shares of the company’s stock in a transaction dated Tuesday, July 25th. The stock was bought at an average price of $2.85 per share, with a total value of $42,750.00. Following the acquisition, the director now owns 238,600 shares in the company, valued at approximately $680,010. The disclosure for this purchase can be found here. In the last 90 days, insiders have acquired 54,100 shares of company stock valued at $155,730 and have sold 25,411 shares valued at $57,893. Company insiders own 27.40% of the company’s stock.
A hedge fund recently bought a new stake in Senestech stock. White Pine Capital LLC purchased a new position in shares of Senestech, Inc. (NASDAQ:SNES) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 19,250 shares of the company’s stock, valued at approximately $110,000. White Pine Capital LLC owned about 0.19% of Senestech as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 15.34% of the company’s stock.
SenesTech, Inc is a United States-based biotechnology platform and research company. The Company is engaged in developing a technology for managing animal populations by fertility control. It offers ContraPest, a fertility control product candidate. ContraPest’s technology and approach targets the reproductive capabilities of both sexes.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Senestech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senestech Inc. and related companies with MarketBeat.com's FREE daily email newsletter.